期刊文献+

肺癌患者新辅助化疗期间出现肝脏肿物11例诊治体会

下载PDF
导出
摘要 肺癌是目前世界上发病率和病死率最高的恶性肿瘤,且其发病率和病死率仍有上升趋势[1]。手术是目前治疗肺癌的首选方法,但早期肺癌很少有明显的症状,大多数发现时已是进展期,失去了手术治疗的机会。近些年来,术前新辅助化疗让一部分原本失去手术机会的肺癌患者可以进行手术治疗。我们在对肺癌患者进行术前新辅助化疗期间(2011年3月~2014年2月)11例出现肝脏肿物,现结合临床资料将诊治体会总结如下。
机构地区 甘肃省肿瘤医院
出处 《山东医药》 CAS 北大核心 2015年第23期103-105,共3页 Shandong Medical Journal
  • 相关文献

参考文献8

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics[ J]. CA Cancer J Clin, 2011,61 (2) :69-90.
  • 2郑庆锋,王宇昭,朱赛楠,刘毅强,李少雷,吴楠,陈晋峰,张力建,杨跃.新辅助化疗及辅助化疗相关循证医学证据的应用对NSCLC治疗的影响[J].中国肿瘤临床,2011,38(4):232-234. 被引量:10
  • 3Song WA, Zhou NK, Wang W, et al. Survival benefit of neoadju- vant chemotherapy in non-small cell lung cancer: an update recta- analysis of 13 randomized control trial [ J ]. J Thbrac Oncol, 2010, 5(4) :510-516.
  • 4Kim YK, Park G, Kim cS, et al. Diagnostic efficacy of gadoxetic acid-enhanced MRI for the detection and cbaracterisation of liver metastases: comparison with multidetector-row CT[ J]. Br J Radi- ol, 2012,85 (1013) :539-547.
  • 5Sacks A, Pellet PJ, Surasi DS, et al. Value of PET/CT in the management of liver metastases, part 1 [ J . A JR Am J Roentgen- ol, 2011,197(2) :256-259.
  • 6Szymezak A, Simon K, Inglot M, et al. Safety and effectiveness of blind percutaneous liver biopsy : analysis of 1412 procedures [ J ]. Hepat Mon, 2012,12( 1 ) :32-37.
  • 7Morris E J, Forman D, Thomas JD, et al. Surgical management and outcomes of colorectal cancer liver metastases [ J ]. Br J Surg, 2010,97(7) :1110-1118.
  • 8Ileana E, Greillier L, Moutardier V, et al. Surgical resection of liver non-small cell lung cancer metastasis: a dual weapon [ J ]. Lung Cancer, 2010,70(2) :221-222.

二级参考文献10

  • 1彭忠民,王潍博,罗静,陈景寒.新辅助化疗对Ⅲ期非小细胞肺癌细胞凋亡和增殖的影响[J].中国肿瘤临床,2005,32(14):798-800. 被引量:4
  • 2Roth JA,Fossella F,Komaki R,et al.A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage Ⅲ A non-small-cell lung cancer[J].J Natl Cancer Inst,1994,86(9):673-680.
  • 3Rosell R,Gomez-Codina J,Camps C,et al.A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer[J].N Engl J Med,1994,330(3):153-158.
  • 4Depierre A,Milleron B,Moro-Sibilot D,et al.Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0),Ⅱ,and Ⅲ a non-small-cell lung cancer[J].J Clin Oncol,2002,20(1):247-253.
  • 5Felip E,Rosell R,Maestre J,et al.Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer[J].J Clin Oncol,2010,28(19):3138-3145.
  • 6Song WA,Zhou NK,Wang W,et al.Survival benefit of neoadjuvant chemotherapy in non-small cell lung cancer:an updated meta-analysis of 13 randomized control trials[J].J Thorac Oncol,2010,5(4):510-516.
  • 7Scagliotti GV,Fossati R,Torri V,et al.Randomized study of adjuvant chemotherapy for completely resected stage Ⅰ,Ⅲ,or Ⅲ A non-small-cell lung cancer[J].Natl Cancer Inst,2003,95(19):1453-1461.
  • 8Arriagada R,Bergman B,Dunant A,et al.Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer[J].New England Journal of Medicine,2004,350:351-360.
  • 9Hotta K,Matsuo K,Ueoka H,et al.Role of adjuvantchemotherapy in patients with resected non-small-cell lung cancer:reappraisal with a meta-analysis of randomized controlled trails[J].J Clin Oncol,2004,22(19):3860-3867.
  • 10Pignon JP,Tribodet H,Scagliotti GV,et al.Lung adjuvant cisplatin evaluation:a pooled analysis by the LACE collaborative group[J].J Clin Oncol,2008,26(21):3552-3559.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部